COMBINATION OF A BCL-2 INHIBITOR AND A MCL-1 INHIBITOR, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF

A combination comprising a BCL-2 inhibitor and a MCL1 inhibitor, and compositions and uses thereof. L'invention concerne une combinaison comprenant un inhibiteur de BCL-2 et un inhibiteur de MCL1, ainsi que des compositions et utilisations associées.

Saved in:
Bibliographic Details
Main Authors MARAGNO, Ana Leticia, POMILIO, Giovanna, MISTRY, Prakash, MAACKE, Heiko, GENESTE, Olivier, HALILOVIC, Ensar, WEI, Andrew, MOUJALLED, Donia, MORRIS, Erick, SANGHAVI, Sneha, CLAPERON, Audrey, WANG, Youzhen, PORTER, Dale
Format Patent
LanguageEnglish
French
Published 25.01.2018
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract A combination comprising a BCL-2 inhibitor and a MCL1 inhibitor, and compositions and uses thereof. L'invention concerne une combinaison comprenant un inhibiteur de BCL-2 et un inhibiteur de MCL1, ainsi que des compositions et utilisations associées.
AbstractList A combination comprising a BCL-2 inhibitor and a MCL1 inhibitor, and compositions and uses thereof. L'invention concerne une combinaison comprenant un inhibiteur de BCL-2 et un inhibiteur de MCL1, ainsi que des compositions et utilisations associées.
Author PORTER, Dale
GENESTE, Olivier
MARAGNO, Ana Leticia
POMILIO, Giovanna
WANG, Youzhen
MISTRY, Prakash
CLAPERON, Audrey
MAACKE, Heiko
MORRIS, Erick
MOUJALLED, Donia
WEI, Andrew
HALILOVIC, Ensar
SANGHAVI, Sneha
Author_xml – fullname: MARAGNO, Ana Leticia
– fullname: POMILIO, Giovanna
– fullname: MISTRY, Prakash
– fullname: MAACKE, Heiko
– fullname: GENESTE, Olivier
– fullname: HALILOVIC, Ensar
– fullname: WEI, Andrew
– fullname: MOUJALLED, Donia
– fullname: MORRIS, Erick
– fullname: SANGHAVI, Sneha
– fullname: CLAPERON, Audrey
– fullname: WANG, Youzhen
– fullname: PORTER, Dale
BookMark eNrjYmDJy89L5WRIcfb3dfL0cwzx9PdT8HdTcFRwcvbRNVLw9PPwdPIM8Q9ScPRzAYr6AkUNEaI6CqHBrsFguQAPxyBfR2fX0BBPZ0cfBaB5Af7BniDzghVCPFyDXP3deBhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJfLi_kYGhhYGhqamRmaOhMXGqAOr5NmI
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate COMBINAISON D'UN INHIBITEUR DE BCL-2 ET D'UN INHIBITEUR DE MCL-1, UTILISATIONS ET COMPOSITIONS PHARMACEUTIQUES ASSOCIÉES
ExternalDocumentID WO2018015526A1
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2018015526A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:42:47 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2018015526A13
Notes Application Number: WO2017EP68453
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180125&DB=EPODOC&CC=WO&NR=2018015526A1
ParticipantIDs epo_espacenet_WO2018015526A1
PublicationCentury 2000
PublicationDate 20180125
PublicationDateYYYYMMDD 2018-01-25
PublicationDate_xml – month: 01
  year: 2018
  text: 20180125
  day: 25
PublicationDecade 2010
PublicationYear 2018
RelatedCompanies LES LABORATOIRES SERVIER
NOVARTIS AG
RelatedCompanies_xml – name: NOVARTIS AG
– name: LES LABORATOIRES SERVIER
Score 3.1333551
Snippet A combination comprising a BCL-2 inhibitor and a MCL1 inhibitor, and compositions and uses thereof. L'invention concerne une combinaison comprenant un...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title COMBINATION OF A BCL-2 INHIBITOR AND A MCL-1 INHIBITOR, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180125&DB=EPODOC&locale=&CC=WO&NR=2018015526A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwEA5jivqmU3E6JaD0yaL9keoehrRpSyu2KbXTvY0lbUGQbriK_76X2rk97S29g6M5-C65NN9XhG5KAJEFO2O1NMRMNQXnKudkppam9UismSZILrnDUWwFY_N5QiYd9LniwjQ6oT-NOCIgSgDe66ZeL9aHWG5zt3J5xz_ANH_ys5GrtN2xJustUVxn5CXMZVShFPo2JU5bHyG6ZUOvtCM30lJp33tzJC9lsbmo-IdoN4F4VX2EOkXVQ_t09e-1HtqL2k_eMGzRtzxGOWWRE_7p12LmYxs79EXVcRgHoRNmLMV27II1Aqu2tt7iMRTNxpcEdhrZ1BtnUgYBQ7yEvYYNkxhngZd6zD9B176X0UCF153-Z2f6zjbnZpyibjWvijOEh0IY_GGY51ppmETcc60QpQb4leRUTvQ-GmyLdL7dfYEO5KM8jdDJAHXrr-_iEtbnml81af0F-iyK2g
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFA5jivNNp-JlakDpk0V7SecehvRKq2tTaqd7G0vagiDdcBX_vqexc3vaWzgHDkngO8mX5DtB6LYAEBmwM5YLjc9knTMmM0ZmcqEbj8SYKZxktXY4jAx_rD9PyKSFPldaGFEn9EcURwREccB7JfL1Yn2I5Yi3lct79gGm-ZOXDh2pYcdKnW-J5FhDN6YOtSXbBt4mRUnjI0Q1TOBKO30ghYIsvVm1LmWxuah4B2g3hnhldYhaedlFHXv191oX7YXNlTc0G_Qtj1Bm09AK_urXYuphE1v2SFZxEPmBFaQ0wWbkgDUEq7K23uExJE3hi30zCU3bHad1GQQM8WL6GgglMU59N3Gpd4xuPDe1fRm6O_2fnek73RybdoLa5bzMTxEecK6x_iDLlELTCX9gSs4LBfBbi1MZUc9Qb1uk8-3ua9Tx03A0HQXRywXar131yYRKeqhdfX3nl7BWV-xKTPEvnYWNxA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMBINATION+OF+A+BCL-2+INHIBITOR+AND+A+MCL-1+INHIBITOR%2C+USES+AND+PHARMACEUTICAL+COMPOSITIONS+THEREOF&rft.inventor=MARAGNO%2C+Ana+Leticia&rft.inventor=POMILIO%2C+Giovanna&rft.inventor=MISTRY%2C+Prakash&rft.inventor=MAACKE%2C+Heiko&rft.inventor=GENESTE%2C+Olivier&rft.inventor=HALILOVIC%2C+Ensar&rft.inventor=WEI%2C+Andrew&rft.inventor=MOUJALLED%2C+Donia&rft.inventor=MORRIS%2C+Erick&rft.inventor=SANGHAVI%2C+Sneha&rft.inventor=CLAPERON%2C+Audrey&rft.inventor=WANG%2C+Youzhen&rft.inventor=PORTER%2C+Dale&rft.date=2018-01-25&rft.externalDBID=A1&rft.externalDocID=WO2018015526A1